[HTML][HTML] Epidemiology of non-alcoholic and alcoholic fatty liver diseases

S Mitra, A De, A Chowdhury - Translational gastroenterology and …, 2020 - ncbi.nlm.nih.gov
Liver diseases are fast emerging as global health priorities. Fatty liver is described in the
setting of non-alcoholic fatty liver disease (NAFLD) as well as alcoholic liver disease (ALD) …

Alcohol use in patients with chronic liver disease

D Fuster, JH Samet - New England Journal of Medicine, 2018 - Mass Medical Soc
Alcohol Use in Patients with Chronic Liver Disease | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

[PDF][PDF] Diagnosis and treatment of alcohol‐associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases

DW Crabb, GY Im, G Szabo, JL Mellinger… - Hepatology, 2020 - Wiley Online Library
Alcohol-associated liver disease (ALD) represents a spectrum of liver injury resulting from
alcohol use, ranging from hepatic steatosis to more advanced forms including alcoholic …

Global burden of alcohol use disorders and alcohol liver disease

J Rehm, KD Shield - Biomedicines, 2019 - mdpi.com
Alcohol use is a major risk factor for burden of mortality and morbidity. Alcoholic liver
disease (ALD) and alcohol use disorders (AUDs) are important disease outcomes caused …

Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis

X Niu, L Zhu, Y Xu, M Zhang, Y Hao, L Ma, Y Li… - BMC Public Health, 2023 - Springer
Background Alcohol related liver disease (ARLD) is one of the major chronic liver diseases
worldwide. This review aimed to describe the global prevalence, incidence, and outcomes of …

[PDF][PDF] Epidemiology of alcohol use and alcoholic liver disease

JL Mellinger - Clinical liver disease, 2019 - Wiley Online Library
Epidemiology of Alcohol Use and Alcoholic Liver Disease Page 1 136 |CliniCal liver Disease,
vOl 13, nO 5, MaY 2019 An Official Learning Resource of AASLD review epidemiology of …

The removal of DAA restrictions in Europe–one step closer to eliminating HCV as a major public health threat

AD Marshall, JM Pawlotsky, JV Lazarus, A Aghemo… - Journal of …, 2018 - Elsevier
Of∼ 10.2 million people with chronic HCV infection in Europe, 6.7 million live in Eastern
Europe, 2.3 million in Western Europe and 1.2 million in Central Europe. HCV transmission …

[HTML][HTML] Alcohol use disorder in community management of chronic liver diseases

L Leggio, JL Mellinger - Hepatology, 2023 - journals.lww.com
Rising rates of alcohol use disorder (AUD) combined with increases in alcohol‐related liver
disease (ALD) and other liver disease have resulted in the need to develop alcohol …

Disparities in uptake of direct‐acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting

ME Socías, L Ti, E Wood, E Nosova, M Hull… - Liver …, 2019 - Wiley Online Library
Abstract Background & Aims Despite the high burden of hepatitis C virus (HCV) infection
among people who inject drugs (PWID), uptake of interferon‐based therapies has been …

Elimination of hepatitis C virus in Australia: laying the foundation

GJ Dore, B Hajarizadeh - Infectious Disease Clinics, 2018 - id.theclinics.com
The development of direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV)
infection is one of the great advances in clinical medicine in recent decades. Involving …